Sanofi, Zealand Diabetes Drug Worked as Well as Lilly's Byetta in Study Bloomberg Sanofi-Aventis SA's experimental diabetes drug lixisenatide, given to volunteer patients once a day, ... UPDATE 1-Sanofi diabetes candidate meets clinical goals Sanofi GLP-1 diabetes drug edges Byetta in Phase III study |
No comments:
Post a Comment